CLAUDIA ANGULO: Open Payments
NPI 1851729776 · SURPRISE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$719 in 27 payments from 14 companies in 2025. Trend: 2023 $423 · 2024 $342 · 2025 $719
Food & beverage: $619Education: $100
| Company | Payments | Amount |
|---|---|---|
| Actelion Pharmaceuticals US, Inc. | 5 | $218 |
| E.R. Squibb & Sons, L.L.C. | 4 | $90 |
| Baxter Healthcare | 1 | $78 |
| Novartis Pharmaceuticals Corporation | 4 | $75 |
| Boston Scientific Corporation | 2 | $41 |
| CARDIVA MEDICAL, INC. | 1 | $35 |
| Abbott Laboratories | 2 | $34 |
| Amgen Inc. | 2 | $31 |
| Inspire Medical Systems, Inc. | 1 | $27 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $19 |
Products named: OPSUMIT, ELIQUIS, Hillrom - Carnation Ambulatory Monitor, LEQVIO, CARDIVA VASCADE MVP VVCS 6-12F, PROCLAIM, REPATHA, CAMZYOS.
Industry payments across AZ — which companies pay providers there.
